An-Hu Li,Ramesh C. Gupta,Mark J. Mulvihill,Anand Narain Rai,Jing Wang
申请号:
US13581619
公开号:
US20120329826A1
申请日:
2011.03.03
申请国别(地区):
US
年份:
2012
代理人:
摘要:
Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by RON and/or MET.